Satellite Allows Digital Mammography Screening for Rural Native Americans

News
Article
Oncology NEWS InternationalOncology NEWS International Vol 16 No 3
Volume 16
Issue 3

A mobile mammography unit that links a digital mammography system with a commercial satellite service provides near real-time interpretation of breast imaging scans to Native American women on remote rural reservations

CHICAGO—A mobile mammography unit that links a digital mammography system with a commercial satellite service provides near real-time interpretation of breast imaging scans to Native American women on remote rural reservations, Marilyn Roubidoux, MD, professor of radiology, University of Michigan Health System, said at the 92nd Annual Meeting of the Radiological Society of North America (RSNA) (abstract SSJ01-04) (see Figures 1 and 2).

In the study, digital mammograms were transmitted by satellite from the Aberdeen Area Indian Health Service, Fort Yates, North Dakota, to the University of Michigan Breast Imaging Division in Ann Arbor. Although the size of the mammography image files was extremely large, transmission time averaged only about 5 minutes per file. The mean turnaround time from image transmission to completion of on-line reading was 50 minutes, but as short as 30 minutes when the conditions for satellite communication were ideal, Dr. Roubidoux said. "The results demonstrate that digital mammograms can be transmitted rapidly by satellite without loss of image quality and can be interpreted remotely," she said.

Because of the rapid turnaround from image acquisition to mammography interpretation, patients in need of follow-up were able to obtain additional breast imaging scans while the mobile mammography unit was still in the area: 58 women were called back for further imaging studies, and 42 of them (72%) had repeat scans performed in the mobile unit on the same day or within 1 to 2 days.

"This project demonstrates efforts by the Sioux tribes and the Indian Health Service to overcome obstacles to screening in remote areas and provide better health care to these women," Dr. Roubidoux said.

The study included 515 mammography examinations performed on 506 women. The mobile mammography unit in the study was equipped with a GE Senograph 2000D digital mammography system, which transmitted screening mammograms via satellite to a GE SenoAdvantage 2.0 workstation, where they were immediately interpreted and reported by radiologists. Turnaround time for reporting included the time required for the transmission of images, receipt of a fax containing a clinical history, interpretation of the screening study by a radiologist, preparation of a paper report, and transmission of the report back to the mobile unit by fax.

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
ADC payloads with high levels of potency can sometimes lead to higher levels of toxicity, which can eliminate the therapeutic window for patients with cancer.
Related Content